ONE-WAYOngoing theme · still written in the latest filings
Rapid Monetization through Direct Launches and Out-Licensing
A business model focused on rapid monetization and sustainable growth by selectively pursuing direct launches or out-licensing of pharmaceutical and medical device R&D pipeline assets in global markets.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.